Shenzhen, China

Ziyuan Di


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ziyuan Di: Innovator in Pharmaceutical Preparation Methods

Introduction

Ziyuan Di is a notable inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of Clopidogrel Hydrogen Sulfate. His innovative methods have the potential to enhance the efficiency and quality of pharmaceutical processes.

Latest Patents

Ziyuan Di holds a patent for a method titled "Method for preparing spherical Clopidogrel Hydrogen Sulfate polymorph I." This invention provides a new preparation method of Clopidogrel Hydrogen Sulfate spherical crystal form I, using single 2-butanol as a solvent. The method involves controlling the concentration, addition way, and addition speed of sulfuric acid used to salify, which shortens the process time. This innovation allows for the stable separation of Clopidogrel Hydrogen Sulfate from the solution system with spherality. The Clopidogrel Hydrogen Sulfate obtained complies with the requirements of the follow-up process on residual solvent, bulk density, and mobility. Ziyuan Di has 1 patent to his name.

Career Highlights

Throughout his career, Ziyuan Di has worked with prominent institutions, including Tianjin University and Shenzhen Salubris Pharmaceuticals Co. Ltd. His work in these organizations has allowed him to develop and refine his innovative methods in pharmaceutical preparation.

Collaborations

Ziyuan Di has collaborated with notable colleagues such as Junbo Gong and Qi Wang. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Ziyuan Di is a distinguished inventor whose work in pharmaceutical preparation methods has the potential to significantly impact the industry. His innovative approach to Clopidogrel Hydrogen Sulfate preparation showcases his commitment to enhancing pharmaceutical processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…